Company Filing History:
Years Active: 2023
Title: Charis L Himeda: Innovator in Gene Editing
Introduction
Charis L Himeda is a notable inventor based in Reno, NV (US). He has made significant contributions to the field of gene editing, particularly in the regulation of gene expression related to DUX4.
Latest Patents
Charis L Himeda holds a patent titled "Silencing of DUX4 by recombinant gene editing complexes." This patent discloses methods and compositions for regulating the expression of DUX4. Specifically, it provides a recombinant gene editing complex that includes a recombinant gene editing protein and a nucleic acid encoding a guide RNA (gRNA) that specifically hybridizes to a target nucleic acid sequence encoding a D4Z4 macrosatellite repeat region. The binding of this complex to the target nucleic acid sequence results in the inhibition of DUX4 gene expression. The methods described in this patent are particularly useful for treating diseases associated with aberrant DUX4 expression, such as facioscapulohumeral muscular dystrophy (FSHD).
Career Highlights
Charis L Himeda is affiliated with the University of Massachusetts, where he continues to advance research in gene editing technologies. His work has garnered attention for its potential applications in treating genetic disorders.
Collaborations
He collaborates with notable colleagues, including Peter L Jones and Takako Jones, who contribute to his research endeavors.
Conclusion
Charis L Himeda's innovative work in gene editing exemplifies the potential of biotechnology to address genetic diseases. His contributions are paving the way for future advancements in the field.